期刊文献+

慢性阻塞性肺疾病中脑钠肽水平的变化及其临床意义 被引量:4

The clinical importance and change of brain natriuretic peptide in diagnosing chronic obstructive pulmonary disease
下载PDF
导出
摘要 目的:探讨慢性阻塞性肺疾病(COPD)及慢性肺心病(CCP)患者血浆脑钠肽(BNP)的水平变化及临床意义。方法:将我科住院治疗的COPD患者60例分为单纯COPD组、CCP急性加重期及其缓解期组。CCP患者分别于急性加重期和缓解期测定血浆BNP水平,与单纯COPD组进行比较,并分析其与动脉血氧分压(PO2)、肺动脉收缩压(PAP)和收缩末期右室内径大小及右室/左室内径的相关性。结果:CCP急性加重期血浆BNP水平为262.84±47.59pg/ml,高于缓解期水平[128.52±24.82pg/ml,P<0.01],且两者均高于单纯COPD组[64.76±12.03pg/ml,P?0.01],急性加重期BNP水平与PO2呈负相关(r=-0.654,P?0.01),与PAP呈正相关(r=0.763,P<0.01),而缓解期BNP水平与PO2无显著相关性(P>0.05)。结论:在COPD伴CCP患者中,血浆BNP水平上升,可能与缺氧、肺动脉高压(PAH)等因素相关。 Objective:To investigate the changes of the levels of plasma brain natriuretic peptide (BNP) in patients with chronic obstructive pulmonary disease (COPD) and chronic cor pulmonale (CCP). Methods : Plasma BNP levels were detected in 30 patients with CCP at acute stage, compared with simple COPD group, and the relationship between it and PO2, pulmonary artery pressure (PAP) was analyzed. Measurements were repeated in the same 30 patients with CCP at remission rage after therapy in hospital. Results: The levels of BNP at acute stage (262.84±47.59)pg/ml and remission stage (128.52±24.82) pg/ml for CCP group were both higher than that in the simple COPD group (64.76±12.03) pg/ml (P〈0.01). Plasma BNP levels were negatively correlated with PO2 (r= -0. 654, P〈0.01) at acute stage, but had no significant correlation at remission stage (P 2〉0.05). In the acute stage of CCP group, BNP levels in the plasma were positively correlated with the PAP(r=0. 763, P〈0.01). Conclusion: Hypoxia and pulmonary artery hypertension may result in elevation of plasma BNP in patients with COPD accompanied with CCP. BNP may involve in the pathophysiological process of CCP.
作者 王煜
出处 《陕西医学杂志》 CAS 2013年第1期18-20,共3页 Shaanxi Medical Journal
关键词 肺疾病 慢性阻塞性/病理生理学 利钠肽 脑/代谢 Pulmonary disease, chronic obstructive/pathophysiology Brain natriuretic peptide, brain/ metabolism
  • 相关文献

参考文献7

  • 1Nishikimi T. Clinical significance of BNP as a biomarker for cardiac disease from a viewpoint of basic science and clinical aspect[J].Nihon Rinsho,2012,(05):774-784. 被引量:1
  • 2Sánchez-Marteles M,Cecilio-Irazola A,Vano-Sanchis D. NT-pro BNP in chronic obstructive pulmonary disease patients[J].Anales Del Sistema Sanitario De Navarra,2009,(02):235-241. 被引量:1
  • 3Stolz D,Breidthardt T,Christ-Crain M. Use of B-type natriuretic peptide in the risk stratification of acute exacerbations of COPD[J].Chest,2008,(05):1088-1094.doi:10.1378/chest.07-1959. 被引量:1
  • 4Inoue Y,Kawayama T,Iwanaga T. High plasma brain natriuretic peptide levels in stable COPD without pulmonary hypertension or Cor pulmonale[J].Internal Medicine,2009,(07):503-512. 被引量:1
  • 5Leuchte HH,Baumgartner RA,Nounou ME. Brain natriuretic peptide is a prognostic parameter in chronic lung disease[J].American Journal of Respiratory and Critical Care Medicine,2006,(07):744-750.doi:10.1164/rccm.200510-1545OC. 被引量:1
  • 6Andreassen AK,Wergeland R,Simonsen S. N-terminal pro B type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension[J].American Journal of Cardiology,2006,(04):525-529. 被引量:1
  • 7Toyama H,Wagatsuma T,Ejima YC. Esarean section and primary pulmonary hypertension:the role of intravenous dexmedetomidine[J].International Journal of Obstetric Anesthesia,2009,(03):262-267. 被引量:1

同被引文献40

  • 1谢盛,程德云.血浆BNP水平对老年COPD患者肺动脉高压及预后的评估意义[J].四川医学,2012,33(11):1899-1901. 被引量:10
  • 2慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8240
  • 3Januzzi JL. Natriuretic peptide testing: a window into the diagnosis and prognosis of heart failure[J]. Cleve Clin J Med, 2006,73(2) : 149-152. 被引量:1
  • 4Inoue Y, Kawayama T, Iwanaga T, et al. High plasma brain natriuretic peptide levels in stable COPD without pulmonary hypertension or eor pulmonale [J]. Intern Med (Tokyo, Japan) ,2009,48(7) :503-512. 被引量:1
  • 5Hoiseth AD, Omland T, Hagve TA, et al. NT-proBNP independently predicts long term mortality after acute exacerbation o{ COPD - a prospective cohort study[J]. Respir Res,2012113,97. 被引量:1
  • 6Gariani K, Delabays A, Perneger natriuretic peptide to detect TV, et al. Use of brain previously unknown left ventricular dysfunction in patients with acute exacerbation of chronic obstructive pulmonary disease[J]. Swiss Med Wkly, 2011,141 : 13298. 被引量:1
  • 7Rubinsztajn R, Nasilowski J, Przybylowski T. Usefulness of NT-proBNP serum level in the diagnosis of dyspnea in COPD patients[J]. Pneumonol Alergol Pol, 2013,81 (1) : 24-29. 被引量:1
  • 8Zhang J, Zhao G, Yu X, et al. Intravenous diuretic and vasodilator therapy reduce plasma brain natriuretic peptide levels in acute exacerbation of ehronic obstructive pulmonary disease[J]. Respirology, 2012,1"7 (4) : 715-720. 被引量:1
  • 9Nishimura K,Nishimura T,Onishi K,et al. Changes in plasma levels of B-type natriuretic peptid'e with acute exacerbations of chronic obstructive pulmonary disease [J ]. Int J Chron Obstruct Pulmon Dis, 2014,9 : 155-162. 被引量:1
  • 10Macchia A, Moncalvo JJR, Kleinert M, et al. Unrecognised ventricular dysfunction in COPD[J]. Eur Respir J, 2012, 39 (1) :51-58. 被引量:1

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部